SEC Form 5 · accession 0001209191-16-119347
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric David
Officer — CSO & EVP Pre-Clinical Dev
Period of report
Mar 31, 2016
Accepted (ET)
May 11, 2016 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 30, 2016 | G | 5,000 | $0.00 | D | 676,306 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involved a charitable contribution by the Reporting Person.
- F2This number does not include 970,000 shares of common stock underlying outstanding options held by Mr. David; post-transaction Mr. David continues to beneficially own or have a right to acquire 1,646,306 shares of common stock.